glutathione increase after treating with platinum drugs

glutathione increase after treating with platinum drugs peroxidase 4‐dependent glutathione high‐consumption drives acquired chemoresistance in lung cancer‐derived brain metastasis - Liu - 2021 - Clinical and Translational Medicine Glutathione-Mediated Conjugation of Anticancer Drugs:

Name: glutathione increase after treating with platinum drugs peroxidase 4‐dependent glutathione high‐consumption drives acquired chemoresistance in lung cancer‐derived brain metastasis - Liu - 2021 - Clinical and Translational Medicine Glutathione-Mediated Conjugation of Anticancer Drugs:
Brand: crisbcreativa.com
SKU: 91526445206
Price: 23.01 USD
Availability: InStock
Rating: 4.0954 (21 reviews)

Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation Platinum resistant ovarian cancer: From mechanisms to treatment strategies ScienceDirect Cysteine metabolic circuitries: druggable targets in cancer British Journal of Cancer Frontiers Glutathione S conjugates as prodrugs to target drug resistant tumors N Acetyl Cysteine as a promising therapeutic approach in ovarian cancer: potential and perspectives PMC

SKU: 91526445206 · From crisbcreativa.com

4.1

USD23.01 USD67.01

Pay in 4 interest-free payments of $5.75 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 14 - Oct 19

Description

It can be anything sensory touch, smell, light, sound, taste, says Kevin Hackshaw, MD, a rheumatologist who specializes in treating patients with fibromyalgia at The Ohio State University Wexner Medical Center in Columbus

The product page notes that the serums pH is 6.00-7.00, or ranging from very mildly acidic to neutral

AU: Conceptualization, Methodology, Writingreview and editing

Such efforts may advance along three critical dimensions: elucidating the precise underlying mechanisms, characterizing the dynamic behavior of biomarkers, and addressing patient heterogeneity